Where is the live CopyMark page for USPTO serial 74250171?

The live record is at https://getcopymark.com/trademark/74250171. Use https://getcopymark.com/trademark/{serialNumber} for any 8-digit USPTO serial.

Who owns ZANTAC TABDOSE?

According to the public USPTO record for serial number 74250171, the listed owner(s) include: Glaxo Group Limited, Glaxo Group Limited.

What is USPTO serial number 74250171?

Serial number 74250171 is the USPTO application identifier for the mark ZANTAC TABDOSE. It is used to track examination, publication, and registration of this trademark.

What is the current status of ZANTAC TABDOSE?

ZANTAC TABDOSE (74250171) currently shows USPTO status code 601 on the public record. This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Which trademark classes cover ZANTAC TABDOSE?

The public record lists International Classes: 005. Each class corresponds to categories of goods or services identified in the application or registration.

Trademark: ZANTAC TABDOSE Serial# 74250171 | status 601; last event ABN1 | Trademark Info & Attorney Guidance

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ZANTAC TABDOSE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner

Monitor this mark, or talk with CopyMark about this registration.

Trademark Monitoring

(312) 319-4460

Not the owner?

File a new U.S. trademark application, or speak with our attorneys.

Start a new application

(312) 319-4460

Owner

Glaxo Group Limited
Greenford, Middlesex UB6 0NN, GB
Other trademarks owned by Glaxo Group Limited
Glaxo Group Limited
Greenford, Middlesex UB6 0NN, GB
Other trademarks owned by Glaxo Group Limited

Goods and services

Class	Description	Status	First use
005	pharmaceutical preparations for the treatment and/or alleviation of ulcers and gastrointestinal disorders	ABANDONED	—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Date	Code	Event	What it means
Dec 18, 1995	ABN1	ABANDONMENT - EXPRESS MAILED	—
Aug 1, 1995	EX5G	SOU EXTENSION 5 GRANTED	—
Jun 15, 1995	EXT5	SOU EXTENSION 5 FILED	—
Nov 23, 1994	EX4G	SOU EXTENSION 4 GRANTED	—
Sep 26, 1994	EXT4	SOU EXTENSION 4 FILED	—
Jun 17, 1994	EX3G	SOU EXTENSION 3 GRANTED	—
May 17, 1994	EXT3	SOU EXTENSION 3 FILED	—
Aug 30, 1993	EX2G	SOU EXTENSION 2 GRANTED	—
Jul 7, 1993	EXT2	SOU EXTENSION 2 FILED	—
Mar 8, 1993	EX1G	SOU EXTENSION 1 GRANTED	—
Jan 22, 1993	EXT1	SOU EXTENSION 1 FILED	—
Dec 15, 1992	NOAM	NOA MAILED - SOU REQUIRED FROM APPLICANT	A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 22, 1992	PUBO	PUBLISHED FOR OPPOSITION	Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 21, 1992	NPUB	NOTICE OF PUBLICATION	—
Jun 15, 1992	CNSA	APPROVED FOR PUB - PRINCIPAL REGISTER	—
Jun 3, 1992	CNEA	EXAMINER'S AMENDMENT MAILED	—
May 14, 1992	CNRT	NON-FINAL ACTION MAILED	A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 4, 1992	DOCK	ASSIGNED TO EXAMINER	—
Apr 29, 1992	DOCK	ASSIGNED TO EXAMINER	—

ZANTAC TABDOSE